ImageneBio (IMA) Accounts Payables (2020 - 2024)

Historic Accounts Payables for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $1.5 million.

  • ImageneBio's Accounts Payables fell 6101.27% to $1.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.5 million, marking a year-over-year decrease of 6101.27%. This contributed to the annual value of $2.1 million for FY2023, which is 129.0% down from last year.
  • Per ImageneBio's latest filing, its Accounts Payables stood at $1.5 million for Q3 2024, which was down 6101.27% from $1.4 million recorded in Q2 2024.
  • ImageneBio's 5-year Accounts Payables high stood at $4.1 million for Q2 2022, and its period low was $1.4 million during Q2 2024.
  • Moreover, its 5-year median value for Accounts Payables was $2.2 million (2020), whereas its average is $2.4 million.
  • Per our database at Business Quant, ImageneBio's Accounts Payables soared by 6730.2% in 2023 and then tumbled by 6101.27% in 2024.
  • Quarter analysis of 5 years shows ImageneBio's Accounts Payables stood at $2.1 million in 2020, then grew by 12.35% to $2.4 million in 2021, then fell by 12.21% to $2.1 million in 2022, then decreased by 1.29% to $2.1 million in 2023, then decreased by 25.46% to $1.5 million in 2024.
  • Its last three reported values are $1.5 million in Q3 2024, $1.4 million for Q2 2024, and $1.9 million during Q1 2024.